Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
UNIQUE HERBAL COMBINATION FOR THE TREATMENT OF ANAL FISSURES AND WOUNDS IN PHARMACEUTICAL DOSAGE FORM
Document Type and Number:
WIPO Patent Application WO/2021/137743
Kind Code:
A1
Abstract:
Integrated pharmaceutical product of herbal combinations produce synergistic effect to treat anal wounds. The current invention relies on the enhanced effect comes from combination of four herbal ingredients namely (Ethanolic Pomegranate Extract, Aqueous Extract of Myrrh, Alum and Aloe Vera Oil). The invented pharmaceutical product can heal anal wounds which are tears or 5 ulcers in the thin-moist tissue (mucosa) that lines the anus. It could be due to trauma, injury, surgery or hemorrhoid. It changes the life of patient and making them suffer from un-tolerated complications such as anal pain and bleeding in the stool. Interestingly, data shows higher and fast treatment in comparison of single herbal treatment.

Inventors:
ALANAZI FARS KAED M (SA)
Application Number:
PCT/SA2020/050019
Publication Date:
July 08, 2021
Filing Date:
December 28, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SAUDI PHARMACEUTICAL IND & MEDICAL APPLIANCES CORPORATION SPIMACO ADDWAEIH (SA)
International Classes:
A61P17/02; A61K33/06; A61K36/185; A61K36/328; A61K36/886
Foreign References:
SA4550B1
FR2152408A11973-04-27
CN112057568A2020-12-11
EP0923935A11999-06-23
FR2768342A11999-03-19
CN105560367A2016-05-11
CN1328836A2002-01-02
CN105232447A2016-01-13
Other References:
N RAHMANI ET AL: "Effects of Aloe vera cream on chronic anal fissure pain, wound healing and hemorrhaging upon defection: a prospective double blind clinical trial", EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 1 January 2014 (2014-01-01), pages 1078 - 1084, XP055387806, Retrieved from the Internet [retrieved on 20170704]
CHIDAMBARA MURTHY K.N. ET AL: "Study on Wound Healing Activity of Punica granatum Peel", JOURNAL OF MEDICINAL FOOD, vol. 7, no. 2, 1 June 2004 (2004-06-01), US, pages 256 - 259, XP055784086, ISSN: 1096-620X, Retrieved from the Internet DOI: 10.1089/1096620041224111
N. RAHMANI 1M. KHADEMLOO2K. VOSOUGHI 1S. ASSADPOUR3: "Effects of Aloe vera cream on chronic anal fissure pain, wound healing and hemorrhaging upon defection: a prospective double blind clinical trial", EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, vol. 18, 2014, pages 1078 - 1084, XP055387806
LOCK MRTHOMSON JPS: "Fissure in ano: the initial management and prognosis", BR J SURG, vol. 64, 1977, pages 355 - 358
MINKES RK1LANGER JC: "A prospective study of botulinum toxin for internal anal sphincter hypertonicity in children with Hirschsprung's disease", J PEDIATR SURG, vol. 35, no. 12, December 2000 (2000-12-01), pages 1733 - 6
NIELSEN MBRASMUSSEN OOPEDERSEN JFCHRISTIANSEN J: "Risk of sphincter damage and anal incontinence after anal dilatation for fissure in ano: An endosonographic study", DIS COLON RECTUM, vol. 36, 1993, pages 677 - 680
LODER PBNICHOLLS RJPHILLIPS RKS: "Reversible chemical sphincterotomy by local appliation of gylceryl trinitrate", BR J SURG, vol. 81, 1994, pages 1386 - 1389
LUND JNSCHOLEFIELD JH: "A randomised, prospective double-blind placebo-controlled trial of glyceryl trinitrate ointment in the treatment of anal fissure", LANCET, vol. 349, 1997, pages 11 - 14, XP004843542, DOI: 10.1016/S0140-6736(96)06090-4
HABEEB FSHAKIR EBRADBURY FCAMERON PTARAVATI MRDRUMMOND AJGRAY AIFERRO VA: "Screening methods used to determine the antimicrobial properties of Aloe vera inner gel", METHODS, vol. 42, 2007, pages 315 - 320, XP022103480, DOI: 10.1016/j.ymeth.2007.03.004
ESHGHI FHOSSEINIMEHR SJRAHMANI NKHADEMLOO MNOROZI MSHOJATI O: "Effects of aloe vera Cream on Posthemorrhoidectomy Pain and Wound Healing: Results of a Randomized, Blind, Placebo-Control Study", J ALTERN COMPLEMENT MED, vol. 6, 2010, pages 647 - 650
KHORASANI GAHOSSEINIMEHR SJAZADBAKHT MZAMANI AMAHDAVI MR: "Aloe versus silver sulfadiazine creams for second-degree burns: a randomized controlled study", SURGERY TODAY, vol. 7, 2009, pages 587 - 591, XP019720743
SUPAYANG P.V.TREECHADA S.SURASAK L.THANOMJIT S.TETSUYA I.TAKESHI H.: "Inhibitory effects of active compounds from Punica granatum pericarp on verocytotoxin production by enterohemorrhagic Escherichia coli 0157:H7", J. HEALTH SCI., vol. 51, no. 5, 2005, pages 590 - 596
AHMED SWANG NHAFEEZ BBCHERUVU VKHAQQI TM: "Punica granatum L. extract inhibits IL-1 beta-induced expression of matrix metalloproteinases by inhibiting the activation of MAP kinases and NF-kappa B in human chondrocytes in vitro", J NUTR, vol. 135, 2005, pages 2096 - 2102
KULKARNI S.S.GOKHALE A.VBODAKE U.MPATHADE G.R.: "Cotton Dyeing with Natural Dye Extracted from Pomegranate (Punica granatum) Peel", UNIVERSAL JOURNAL OF ENVIRONMENTAL RESEARCH AND TECHNOLOGY, vol. 1, no. 2, 2011, pages 135 - 139
GUO, C. J.YANG, J. J.WEI, J. Y.LI, Y. F.XU, J.JIANG, Y. G.: "Antioxidant activities of peel, pulp and seed fractions of common fruits as determined by FRAP assay", NUTRITION RESEARCH, vol. 23, 2003, pages 1719 - 1726, XP009057841, DOI: 10.1016/j.nutres.2003.08.005
ABDEL MONEIM A.E.: "Antioxidant activities of Punica granatum (pomegranate) peel extract on brain of rats", JOURNAL OF MEDICINAL PLANTS RESEARCH, vol. 6, no. 2, 2012, pages 195 - 199
YUNFENG, L.G. CHANGJIANGJ. YANGJ. WEIJ. XUS. CHENG: "Evaluation of antioxidant properties of pomegranate peel extract in comparison with pomegranate pulp extract", FOOD CHEM, vol. 96, no. 96, 2006, pages 254 - 260
QU WPAN ZZHANG RMA HCHEN XATUNGULU GG: "Integrated extraction and anaerobic digestion process for recovery of nutraceuticals and biogas from pomegranate marcs", TRANS ASABE, vol. 52, no. 6, 2009, pages 1997 - 2006
QU WPAN ZMA H: "Extraction modeling and activities of antioxidants from pomegranate marc", J FOOD ENG, vol. 99, no. 1, 2010, pages 16 - 23, XP026979122
LONGTIN, R.: "The pomegranate: nature's power fruit", JOURNAL OF NATIONAL CANCER INSTITUTE, vol. 95, 2003, pages 346 - 348
NASR, C. B.AYED, N.METCHE, M.: "Quantitative determination of the polyphenolic content of pomegranate peel", Z LEBENSM UNTERS FORSCH, vol. 203, 1996, pages 374 - 378, XP009016018, DOI: 10.1007/BF01231077
UMADEVI M.KUMAR P.K.S.BHOWMIK D.DURAIVEL S.: "Medicinal Plants with Potential Antifertility Activity", JOURNAL OF MEDICINAL PLANTS STUDIES, vol. 1, no. 1, 2013, pages 26 - 33
AMPASAVATE C.OKONOGI S.ANUCHAPREEDA S.: "Cytotoxicity of extracts from fruit plants against leukemic cell lines", AFR. J. PHARM. PHARMACOL, vol. 4, no. 1, 2010, pages 13 - 21
ABDUL GANY Z.S.GEDHAN A.F.HUSSEN R.A.: "The Cytotoxic Activity of Punica granatum on Growth of Hela and REF Cell Lines", IRAQI JOURNAL OF CANCER AND MEDICAL GENETICS, vol. 3, no. 1, 2010, pages 7 - 10
ASHOUSH I.S.EL-BATAWY O.I.EL-SHOURBAGY G.A.: "Antioxidant activity and hepatoprotective effect of pomegranate peel and whey powders in rats", ANN. AGRIC. SCI., 2013, Retrieved from the Internet
HONTECILLAS RO'SHEA MEINERHAND ADIGUARDO MBASSAGANYA-RIERA J: "Activation of PPAR gamma and alpha by punicic acid ameliorates glucose tolerance and suppresses obesity-related inflammation", J AM COLL NUTR, vol. 28, no. 2, 2009, pages 184 - 95
MURTHY K.N.REDDY V.K.VEIGAS J.M.MURTHY U.D.: "Study on wound healing activity of Punica granatum peel", J. MED. FOOD., vol. 7, 2004, pages 256 - 259
EL ASHRY,E.S.RASHED,N.SALAMA,O.M.SALEH,A.: "Components, therapeutic value and uses of myrrh", PHARMAZIE, vol. 58, 2003, pages 163 - 168
MASSOUD, A.: "Preliminary study of therapeutic efficacy of a new fasciolicidal drug derived from Commiphora molmol (myrrh", THE AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, vol. 65, 2001, pages 96 - 99
ABO-MADYAN AAMORSY TAMOTAWEA SM.: "Efficacy of Myrrh in the treatment of schistosomiasis (haematobium and mansoni) in Ezbet El-Bakly, Tamyia Center, El-Fayoum Governorate, Egypt.", J EGYPT SOC PARASITOL., vol. 34, no. 2, 2004, pages 423 - 446
SU S.WANG T.CHEN T.DUAN J.YU L.TANG Y.: "Cytotoxicity activity of extracts and compounds from Commiphora myrrha resin against human gynecologic cancer cells", J. MED. PLANT. RES., vol. 5, no. 8, 2011, pages 1382 - 1389
"European Drugs Encyclopedia", article "Commiphora (Myrrha (Commiphora molmol)),Product Characteristics - Assessment Report"
ABDALLAH E.M.KHALID A.S.IBRAHIM N.: "Antibacterial activity of oleo-gum resins of Commiphora molmol and Boswellia papyrifera against methicillin resistant Staphylococcus aureus (MRSA", SCIENTIFIC RESEARCH AND ESSAY, vol. 4, no. 4, 2009, pages 351 - 356
SHEN T.HUILI G.WANGA X.XIANGLOU H.: "The genus Commiphora: A review of its traditional uses, phytochemistry and pharmacology", JOURNAL OF ETHNOPHARMACOLOGY, vol. 142, 2012, pages 319 - 330
ZHU, N.Q.SHENG,S.Q.SANG,S.M.: "Isolation and characterization of several aromatic sesquiterpenes from Commiphora myrrha", FLAVOUR FRAGRANCE JOURNAL, vol. 18, 2003, pages 282 - 285
EHAB AALANAZI F ET AL.: "A novel triple suppository of pomegranate, alum and myrrah for fast treatment of hemorrhoids", 2015, SAUDI PATENT OFFICESAUDI PATENT OFFICE
Attorney, Agent or Firm:
AL HADAF MARKS SERVICES LLC (SA)
Download PDF:
Claims:
Claims

1. A pharmaceutical composition comprising:

- 5-20% w/w of ethanolic pomegranate peel extract, - 5- 20% w/w of aqueous Myrrh extract,

- 5-20% w/w Alum, and

- a pharmaceutical carrier.

2. The pharmaceutical composition according to claim 1 further comprising < 5% w/w Aloe Vera oil. 3. The pharmaceutical composition according to claim 1, for use in the treatment of anal wounds in a subject in need thereof.

4. The pharmaceutical composition according to claim 2 wherein the anal wound is hemorrhoids and/or anal fissure

5. The pharmaceutical composition of claim 1, wherein said pharmaceutical carrier is selected, but not limited to, suppository base, ointment base, cream, gel, emulsion or lotion.

Description:
Unique Herbal Combination for the Treatment of Anal Fissures and Wounds in Pharmaceutical Dosage form

Full description

Background of the invention

Anal wounds are a common painful disorder of the anal area that are characterized by un tolerated pain upon defecation, anal bleeding, and anal sphincter spasms (1). Anal wounds are usually caused by trauma or injury to the anal canal while passing hard or large stools, constipation, diarrhea or childbirth (2). It could end with difficulty with bowel movements with severe pain and discomfort; till leading to major complications like clotting.

Treatment usually includes adopting simple methods to have stool soft such as increasing fiber and fluid intake to roll out the reason behind the formation of new wounds. Traditional practice such as soaking in warm water for 10-20 minutes as often as possible, particularly after bowel movements, also helps with healing and reducing discomfort. If symptoms still persist, further treatment is required which involves initially using special cream based. Topical anesthetics and pain medication may also be prescribed to control pain. Sometimes, injection of botulin toxin into the internal anal sphincter could be used as alternative treatment (3).

However, some patients with acute conditions do not heal and become chronic wounds. Surgery is recommended if the symptoms do not respond to conservative treatment. Anal surgery is aimed to re-establish the conditions which lead to healing of the small mucosa tears. This includes either a partial division of the internal sphincter (sphincterotomy) or manual dilatation of the anus. Surgical treatment for this condition has been associated with the side-effect and incontinence in up to 30% of patients (4). Therefore, a non-surgical method for the treatment of chronic anal fissures is highly desirable.

Over the past few years, a number of clinical studies have shown that topical application of ointments promotes the healing of chronic anal wounds (5). The important of development depends on the composition of the healing ingredients since some of them have complicated side effects (6). Wound healing is a complex multifactorial process that results in the contraction and closure of the wound and restoration of a functional barrier (35). Repair of injured tissues occurs as a sequence of events, which includes inflammation, proliferation and migration of different cell types .The difficulties in treatment becomes more challenges especially in case of possibility of wound become infected by fecal bacteria.

Aloe vera (L.) Burm. f. belongs to the Xanthorrhoeaceae plant family and has long been used as a traditional medicine. It is one of the most recognizable herbs in the world and the medicinal part of this plant is the succulent leaf. Aloe vera juice is obtained by breaking or slicing a leaf and is the principal part of the plant that is used in herbal medicine. It also has pharmacological properties that have been shown to provide antioxidant, wound healing, antibacterial, antifungal, and immunomodulatory effects (7). Recently, it has been shown that Aloe vera cream can facilitate wound healing in post hemorrhoidectomy patients (8). In addition, another study demonstrated that an aloe cream reduced the healing time in patients with burn injuries compared to silver cream

(9).

Pomegranate is one of the important fruits stated in Qur’an. Punica granatum belongs to the family of Punicaceae, is commonly known as pomegranate, grenade, granats and punica apple

(10). Pomegranate extract are becoming popular in the Western world for the treatment and prevention of arthritis and other inflammatory diseases (11). Pomegranate peels have been used since antiquity in the Middle East as colorant for textiles because of their high tannin and phenolic contents (12). Also, among the peel, pulp and seed pomegranate peel had the highest antioxidant activity (13, 14-17). In many culture’s folk medicine pomegranates have been used extensively (18). Pomegranate peel contains large amounts of polyphenols such as ellagic tannins, ellagic acid and gallic acid. It has been used in the preparation of tinctures, cosmetics, therapeutic formulae and food recipes (19) Dried fruit peel is used for diarrhea and to treat respiratory and urinary tract infections (20). Anti- fertility effect (21) cytotoxic activity (22,23) hepatoprotective activity (24) and hypoglycemic activity (25). MURTHY et al, (26) studied the wound healing activity of phenol-rich methanolic extract of dried pomegranate peel on the skin of Wistar rats. Following the application of the extract, formulated as a water-soluble gel, the animals treated with 5% gel showed complete healing after 10 days. Myrrh, is the stem resinous exudates belonging to different Commiphora species according to their growing area. It is an oleo-gum resin that form emulsion upon mixing with water. Published researches showed different medicinal effects for myrrh. The medical uses including fasciolicidal effect, and in the treatment of schistosomiasis (27-29). Myrrh as a whole or some of its components appear to have many therapeutic effectiveness in the treatment of different diseases as treating gynecologic cancer disease (30), anaesthetic, antibacterial, antifungal and antihyperglycemic (31,32). Other medicinal use include antiulcer, antipyretic, analgesic, antioxidant and anti-inflammatory (31, 33). Myrrh contained about 2-8% essential oil, 40-60% water-soluble gum and 23-40% alcohol-soluble resins. The essential oil was rich in furanosesquiterpenoids where about 20 compound have been isolated (34).

Many scientific reports were published for single use of the invention four ingredients for wound healing (7-34). Three combination of herbal ingredients were also presented by Ehab at el., (35). None of the prior art documents has provided the synergistic effect of four ingredient working for the treatment of anal wounds unexpectedly and for the first time.

Summary of the invention

The present invention relates to an integrated herbal pharmaceutical composition for producing a synergistic effect for the treatment of anal wounds.

The said composition comprises an ethanolic extract of pomegranate peel, aqueous extract of myrrh and alum (potassium aluminum sulfate), and a pharmaceutical carrier.

The composition may further comprises Aloe Vera oil.

In a preferred embodiment, the said components are present in a range of 5-20% wt/wt.

In a further embodiment, the composition also comprises < 5% w/w Aloe Vera oil wt/wt.

The present invention is considered innovative because it unexpectedly provides a synergistic effect of the ingredients of said composition, working in combination for the treatment of anal wounds for the first time. In the closest prior art, Saudi patent 4550, it was disclosed that the components comprise different extracts. It is well known for a person skilled in the art that ethanolic and aqueous extraction procedures result in different extracts. In the current invention, ethanolic pomegranate peel extract was used while in 4550, aqueous pomegranate peel extract was used. Oppositely also, in the current invention, aqueous extract for myrrh was used while in the 4550, ethanolic extract from myrrh was used. Also, the additional use of Aloe Vera oil in the current invention provides for a four- component mixture which results in an increased wound healing as compared to Aloe Vera oil alone or the three-component mixture described in 4550 or herein.

Brief description of the drawings:

Figure 1: Pictures of the prepared suppositories.

Figure 2A: The rectum weight data for : Group 1 (negative control); Group 2 ( positive control ), Group 3 (administered suppository containing only Pomegranate); Group 4 (administered suppository containing only Myrrh), Group 5 (administered suppository containing only Alum), Group 6 (administered suppository containing only Aloe vera oil), Group 7 (administered the prepared suppositories containing: Pomegranate + Myrrh+ Alum), Group 8 (administered the prepared suppositories containing: Pomegranate + Myrrh+ Alum + Aloe vera oil). * presented statistically significant from others treatments; (p< 0.05).

Figure 2B: The percentage reduction in rectum weight data for Group 3 (administered suppository containing only Pomegranate); Group 4 (administered suppository containing only Myrrh), Group 5 (administered suppository containing only Alum), Group 6 (administered suppository containing only Aloe vera oil), Group 7 (administered the prepared suppositories containing: Pomegranate + Myrrh+ Alum), Group 8 (administered the prepared suppositories containing: Pomegranate + Myrrh+ Alum + Aloe vera oil).

Figures 3-10: show images of rectal (anus) tissues for wistar rats as follows: Figure 3: Negative control (normal animals); Figure 4: Positive Control (untreated wounds); Figure 5: Pomegranate suppository treated animals; Figure 6: Myrrh suppositoiy base treated animals; Figure 7: Alum suppository treated animals; Figure 8: Aloe Vera oil suppository treated animals; Figure 9: Alum+ Pomegranate + Myrrh suppository treated animals; and Figure 10: Alum+ Pomegranate + Myrrh+ Aloe Vera oil suppository treated animals

Detailed description Methodology:

The herbal extracts were purchased from GMP supplier (Table 1). All chemical used are of analytical or pharmaceutical grade.

Table 1: Source of herbal and medicated substances.

Specification of Prepared Suppositories:

The following table shows the pharmaceutical specification of the prepared suppositories. Table 2: the prepared suppositories pharmaceutical specification

Pharmaceutical Composition

The pharmaceutical composition intended for use as a medicament for the treatment of anal wounds, both internal and external use, comprises:

(a) 5-20% w/w of ethanolic pomegranate peel extract,

(b) 5- 20% w/w of aqueous myrrh extract,

(c) 5-20% w/w alum, and

(d) a pharmaceutical carrier.

In a preferred embodiment of the current invention, the components are in the following ranges:

(a) 10-15% w/w of ethanolic pomegranate peel extract,

(b) 10-15% w/w of aqueous myrrh extract,

(c) 10-15% w/w alum, and (d) a pharmaceutical carrier.

In a further preferred embodiment, the ethanolic pomegranate peel extract is present is greater than 10% w/w, the aqueous myrrh extract is greater than 10% w/w, the alum is greater than 10% w/w and the Aloe Vera oil is lower than 10% w/w.

In yet a further embodiment, the pharmaceutical composition comprises between 1-20% w/w Aloe Vera oil, preferably between 1-5% w/w Aloe Vera oil. Induction of anal wounds:

Hemorrhoids were induced in male wistar rats by a modification of the methods described by Nishiki et al. (31) and Okumura et al.(32). In brief: male wistar rats (250±5g body weight) were used in this study. All rats were fasted from food for 3 days but allowed drinking water ad libitum. To induce hemorrhoids a mixture of 6% croton oil in diethyl ether: pyridine: diethyl ether: water in the ratio of 10: 4 : 5: 1 (v/v) was used.

On the day of experiment each rat was immobilized in restrainer cage. The tampon of an ear cotton bud (produced by septona SA, Greece and purchased from the local market in Riyadh, kingdom of Saudi Arabia) was dipped in 10 ml of the above inducer contained in a 10 ml vial for 60 seconds. Then it was inserted into the rectum and allowed to contact the mucosa to a depth of 2cm for 60 seconds and then removed smoothly. The animals were freed from their restrainers and placed in their cages with no food or water for complete 4 hours. The volume of the inducer absorbed by each tampon was 333 mΐ. The animals were then sacrificed by an overdose of diethyl ether. The lower abdomen was opened, all of the reproductive organs removed, the hip bone cut and the lower rectum cleared from any adhering tissues. Then a rectum-anus portion measuring 2 cm was cut from each rat starting from the circular hairline on the anus epithelium using a pair of campus and a pair of scissors. The cut piece was then opened longitudinally, blotted on a piece of filter paper and weighed immediately. The weight of tissues corresponding to 150 g body weight was then calculated in mg.

Treatment of animals with the prepared suppositories

Male wistar rats (250±5g body weight) were fasted from food for 3 days but allowed drinking water ad libitum. The animals were divided into 3 groups:

Group 1 (negative control) (not administered any suppository without wound inducing) but the cotton bud was immersed in distilled water only.

Group 2,( positive control ) administered plain suppository.

Group 3, administered suppository containing only Pomegranate Group 4, administered suppository containing only Myrrh Group 5, administered suppository containing only Alum Group 6, administered suppository containing only Aloe vera oil

Group 7, administered the prepared suppositories containing: Pomegranate + Myrrh+ Alum Group 8, administered the prepared suppositories containing: Pomegranate + Myrrh+ Alum + Aloe vera oil (four ingredients’ combination suppository)

Each suppository was allowed to contact the rectum for 1 hour. During this time, the anus was closed using a large bull-dog. Thereafter, the bull-dog was removed. The percentage reductions in the weights of recti of the treated animals were then calculated relative to the control weights (Table 3).

Table 3: Rat rectum weight of normal and treated rats after simulation of hemorrhoid

It is clear from the data that the invented formula has tremendously reduced the weight of the rectum which is statistically significant from other treatment (p< 0.05) (Table 3, Figure 2A and Figure 2B). The new invented formula with addition of Aloe Vera oil has more pronounced effect comparing to single treatment or the three combination. This because wound healing is complex process which needs more treatments modalities that may sometime synergies internal healing processes. For instance, Aloe vera preparations have many biological effects, including immunomodulatory, anti-inflammatory, antioxidant, and wound healing properties (36). These properties were synergized with Pomegranate, Myrrh and Alum. It is evidently that figures 3-10 confirm previous results in rectum weight study. Normal mucosa and Normal blood vessels was shown with negative control group (Figure 3). Differently, in case of (Positive Control), it shows presence of edema in mucosa and submucousa, ulceration on surface, sever damage, extensive necrosis (Figure 4). In case of Pomegranate suppository, Skin appears normal with small Congested blood vessels meaning the need of improvement (Figure 5). Similarly, with Myrrh suppository Congested blood vessels and dilatation was existing (Figure 6). Due to the effect of Alum on blood vessels, Alum suppository had less necrosis in mucosa less hemorrhage (Figure 7). In case of Aloe Vera oil suppository, blood vessels still congested and dilated (Figure 8). The suppositories containing the three combination (Alum+ Pomegranate + Myrrh) showed that blood vessels still congested and dilated with no necrosis. To make the wound healing more alleviated, the synergistic action of the four ingredient was induced in (figure 10). Blood vessels completely healed and thick wall arterioles appears normal size.

List of symbols used in the figures: G: groups

RW: rectum weight (mg)

Y: % reduction in mass (mg)

References

1. N. RAHMANI 1, M. KHADEML002, K. VOSOUGHI 1, S. ASSADPOUR3, Effects of Aloe vera cream on chronic anal fissure pain, wound healing and hemorrhaging upon defection: a prospective double blind clinical trial, European Review for Medical and Pharmacological Sciences, 2014; 18: 1078-1084

2. LOCK MR, THOMSON JPS. Fissure in ano: the initial management and prognosis. Br J Surg 1977; 64: 355-358.

3. Minkes RK1, Langer JC, A prospective study of botulinum toxin for internal anal sphincter hypertonicity in children with Hirschsprung's disease. J Pediatr Surg. 2000 Dec;35(12): 1733-6.

4. NIELSEN MB, RASMUSSEN OO, PEDERSEN JF , CHRISTIANSEN J. Risk of sphincter damage and anal incontinence after anal dilatation for fissure in ano: An endosonographic study. Dis Colon Rectum 1993; 36:677-680.

5. LODER PB, NICHOLLS RJ, PHILLIPS RKS. Reversible chemical sphincterotomy by local appliation of gylceryl trinitrate.Br J Surg 1994;81:1386-1389.

6. LUND JN, SCHOLEFIELD JH. A randomised, prospective double-blind placebo- controlled trial of glyceryl trinitrate ointment in the treatment of anal fissure. Lancet 1997; 349:11-14.

7. HABEEB F , SHAKIR E, BRADBURY F , CAMERON P , TARAVATI MR, DRUMMOND AJ, GRAY AI, FERRO VA. Screening methods used to determine the antimicrobial properties of Aloe vera inner gel. Methods 2007; 42:315-320.

8. ESHGHI F , HO S SEINIMEHR SJ, RAHMANI N, KHADEMLOO M, NOROZI MS, HOJAH O. Effects of aloe vera Cream on Posthemorrhoidectomy Pain and Wound Healing: Results of a Randomized, Blind, Placebo-Control Study. J Altern Complement Med 2010;6:647-650.

9. KHORASANI GA, HO S SEINIMEHR SJ, AZADBAKHT M, ZAMANI A, MAHDAVI MR. Aloe versus silver sulfadiazine creams for second-degree burns: a randomized controlled study. Surgery Today 2009; 7: 587-591.

10. Supayang P.V., Treechada S., Surasak L., Thanomjit S., Tetsuya I, Takeshi H,

Inhibitory effects of active compounds from Punica granatum pericarp on verocytotoxin production by enterohemorrhagic Escherichia coli 0157:H7. J. Health Sci. 51(5):590- 596, (2005).

11. Ahmed S, Wang N, Hafeez BB, Cheruvu VK, Haqqi TM: Punica granatum L. extract inhibits IL-1 beta-induced expression of matrix metalloproteinases by inhibiting the activation of MAP kinases and NF-kappa B in human chondrocytes in vitro. J Nutr, 135:2096-2102, (2005).

12. Kulkarni S.S., Gokhale A.V, Bodake U.M, Pathade G.R., Cotton Dyeing with Natural Dye Extracted from Pomegranate ( Punica granatum) Peel, Universal Journal of Environmental Research and Technology, 1 (2): 135-139, (2011). 13. Guo, C. J., Yang, J. J., Wei, J. Y., Li, Y. F., Xu, J., & Jiang, Y. G. Antioxidant activities of peel, pulp and seed fractions of common fruits as determined by FRAP assay.

Nutrition Research, 23, 1719-1726, (2003).

14. Abdel Moneim A.E., Antioxidant activities of Punica granatum (pomegranate) peel extract on brain of rats, Journal of Medicinal Plants Research, 6(2):195-199, (2012)

15. Li Y, Guo C, Yang J, Wei J, Xu J, Cheng S. Evaluation of antioxidant properties of pomegranate peel extract in comparison with pomegranate pulp extract. Food Chem, 2(96): 254-260, (2006).

16. Qu W, Pan Z, Zhang R, Ma H, Chen X, Atungulu GG. Integrated extraction and anaerobic digestion process for recovery of nutraceuticals and biogas from pomegranate marcs. Trans AS ABE, 52(6): 1997-2006, (2009).

17. Qu W, Pan Z, Ma H. Extraction modeling and activities of antioxidants from pomegranate marc. J Food Eng, 99(1): 16-23, (2010) .

18. Longtin, R. The pomegranate: nature’s power fruit. Journal of National Cancer Institute, 95, 346-348, (2003).

19. Nasr, C. B., Ayed, N., & Metche, M.. Quantitative determination of the polyphenolic content of pomegranate peel. Z Lebensm Unters Forsch, 203, 374-378, (1996).

20. Yunfeng, L., G. Changjiang, J. Yang, J. Wei, J. Xu, and S. Cheng. Evaluation of antioxidant properties of pomegranate peel extract in comparison with pomegranate pulp extract. Food Chem. 96, 254-260, (2006).

21. Umadevi M. , Kumar P.K.S. , Bhowmik D. , Duraivel S., Medicinal Plants with Potential Antifertility Activity, Journal of Medicinal Plants Studies, 1(1): 26-33, (2013)

22. Ampasavate C., Okonogi S., Anuchapreeda S., Cytotoxicity of extracts from fruit plants against leukemic cell lines, Afr. J. Pharm. Pharmacol, 4(1): 13-21, (2010).

23. Abdul gany Z.S., Gedhan A.F., Hussen R.A., The Cytotoxic Activity of Punica granatum on Growth of Hela and REF Cell Lines, Iraqi Journal of Cancer and Medical Genetics, 3(1): 7-10, (2010).

24. Ashoush I.S., El-Batawy O.I., El-Shourbagy G.A., Antioxidant activity and hepatoprotective effect of pomegranate peel and whey powders in rats, Ann. Agric. Sci. (2013), http://dx.doi.Org/10.1016/j.aoas.2013.01.005

25. Hontecillas R, O'Shea M, Einerhand A, Diguardo M, Bassaganya-Riera J. Activation of PPAR gamma and alpha by punicic acid ameliorates glucose tolerance and suppresses obesity-related inflammation. J Am Coll Nutr. 28(2): 184-95, (2009).

26. MURTHY K.N., REDDY V.K., VEIGAS J.M., MURTHY U.D.: Study on wound healing activity of Punica granatum peel. /. Med. Food., 2004, 7, 256-259.

27. El Ashry,E.S., Rashed,N., Salama,O.M., Saleh, A., Components, therapeutic value and uses of myrrh. Pharmazie 58,163-168, (2003).

28. Massoud, A. preliminary study of therapeutic efficacy of a new fasciolicidal drug derived from Commiphora molmol (myrrh). The American Journal of Tropical Medicine and Hygiene 65,96-99, (2001).

29. Abo-Madyan AA, Morsy TA, Motawea SM., Efficacy of Myrrh in the treatment of schistosomiasis (haematobium and mansoni) in Ezbet El-Bakly, Tamyia Center, El- Fayoum Governorate, Egypt., J Egypt Soc Parasitol.;34(2);423-446 (2004). 30. Su S., Wang T., Chen T., Duan J., Yu L., Tang Y., Cytotoxicity activity of extracts and compounds from Commiphora myrrha resin against human gynecologic cancer cells, J. Med. Plant. Res., 5(8), 1382-1389, ( 2011)

31. European Drugs Encyclopedia, Commiphora (Myrrha (Commiphora mo lmol)), Product Characteristics - Assessment Report, htp://www.theodora.com/drugs/eu/myrrha commiphora molmol herbal.html

32. Abdallah E.M., Khalid A.S., Ibrahim N., Antibacterial activity of oleo-gum resins of Commiphora molmol and Boswellia papyrifera against methicillin resistant Staphylococcus aureus (MRSA), Scientific Research and Essay, 4 (4); 351-356, (2009). 33. Shen T., HuiLi G., Wanga X., XiangLou H., The genus Commiphora: A review of its traditional uses, phytochemistry and pharmacology, Journal of Ethnopharmacology 142: 319-330, (2012).

34. Zhu, N.Q.,Sheng,S.Q.,Sang,S.M., Isolation and characterization of several aromatic sesquiterpenes from Commiphora myrrha. Flavour Fragrance Journal 18, 282-285, (2003).

35. Ehab A, Alanazi F, et al,. A novel triple suppository of pomegranate, alum and myrrah for fast treatment of hemorrhoids. Saudi patent office , 2015, No ( 4550) 36. N. RAHMANI1, M. KHADEML002, K. VOSOUGHI1, S. ASSADPOUR, Effects of

Aloe vera cream on chronic anal fissure pain, wound healing and hemorrhaging upon defection: a prospective double blind clinical trial, European Review for Medical and Pharmacological Sciences, 2014; 18: 1078-1084